Cytogam is a Intravenous Liquid in the Plasma Derivative category. It is labeled and distributed by Saol Therapeutics Inc.. The primary component is Human Cytomegalovirus Immune Globulin.
Product ID | 70257-532_2a40733c-106b-41cf-94f0-f10a03180ac8 |
NDC | 70257-532 |
Product Type | Plasma Derivative |
Proprietary Name | Cytogam |
Generic Name | Cytomegalovirus Immune Globulin Intravenous (human) |
Dosage Form | Liquid |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-10-30 |
Marketing Category | BLA / BLA |
Application Number | BLA103189 |
Labeler Name | Saol Therapeutics Inc. |
Substance Name | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [EXT],Immunoglobulins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-10-30 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
44206-532 | Cytogam | Human Cytomegalovirus Immune Globulin |
70257-532 | Cytogam | Cytomegalovirus Immune Globulin Intravenous (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CYTOGAM 85238921 4025755 Dead/Cancelled |
CSL Behring AG 2011-02-10 |
CYTOGAM 77522611 not registered Dead/Abandoned |
CSL Behring AG 2008-07-15 |
CYTOGAM 74178919 1742103 Live/Registered |
SAOL BERMUDA LIMITED 1991-06-21 |